• Prof Linda Mcgowan talks about research in persistent pelvic pain in general practice to improve the management of those with pelvic pain.

1st World Congress on Pelvic Pain, Amsterdam 2013. Research Gaps and Priorities final report

Endometriosis: Improving the wellbeing  of couples. Report and recommendations 2013REPORT OF A WORKSHOP: PATIENT AND PROFESSIONAL

REPORT OF A WORKSHOP: PATIENT AND PROFESSIONAL PERSPECTIVES OF CHRONIC PELVIC PAIN:- 2nd World Congress on Abdominal and Pelvic Pain, Nice 2015 (Revised 2016)


November 2016:  The following trial is currently recruiting at several sites in the UK. Please see information about the trial below.  

The GaPP2 trial


The GaPP2 trial is testing gabapentin in women with chronic pelvic pain.  The GaPP2 researchers want to find out if gabapentin reduces chronic pelvic pain, if there are any side effects of the medicine and how it works.

Gabapentin is a drug that was developed to treat epilepsy, and is currently used to relieve neuropathic pain.

GaPP2 is a randomised, double-blind, placebo-controlled trial:

Randomised: The women who take part will be given either the treatment medicine (gabapentin) or a placebo - a dummy drug that has no active ingredients.  A computer makes the selection so it's completely random.

Double-blind The women in the trial won't be told whether they are taking the active medicine (gabapentin) or the placebo - and neither will their doctors.  So both are "blinded" to this information.

Placebo-controlled Half of the women in the study will have the active medicine and half the placebo (they are called the control group).  The medication that women receive will look exactly the same to them and their doctors, but a completely separate study group will keep a record of which women have gabapentin and which have the placebo.

If you might be interested in taking part in the GaPP2 trial, here's what you need to know

Who can take part

You may be eligible for the GaPP2 trial if you:

Are between 18-50 years

Have chronic pelvic pain of more than 3 months duration

Have had a laparoscopy that could not find the cause of your pain

Are using or willing to use effective contraception if necessary to avoid pregnancy

What the trial involves

We will collect information on pain, and physical and emotional wellbeing at the beginning of the study and after 12 weeks of treatment by questionnaire. Additionally, we will ask a subset of 50 women (recruited in Edinburgh) to have a scan to look at brain activity before and during treatment. We will analyse the brain scan findings to further understand how gabapentin works in women with chronic pelvic pain and possibly also other pain conditions.

The following hospitals are recruiting patients:

Aberdeen Maternity Hospital

Danielle Pirie, Research nurse. 01224 438306  

Birmingham Women's Hospital

Virginia Iqbal. Research Nurse.   07808200148

Julie Tebbutt Research Midwife & Nurse.  01296 418160
Mobile: 07833 095349


Chester: Countess of Chester Hospital

Nichola Kearsley Gynaecology Research Nurse.  01244 363379

Edinburgh Royal Infirmary
Priscilla Fernandez,Research Nurse.  0131 242 3001


Glasgow: Queen Elizabeth University Hospital

Therese McSorley, Research nurse.  0141 232 7600 or 07794692070 

Liverpool Women's Hospital

Pam Corlett, Research nurse. or  0151 702 4496 

Manchester, St Mary's Hospital

Katie Swindells, Research nurse.  0161 276 6478  

Middlesborough: James Cook University Hospital

Sarah Croft. Research  01642 835913 

Oxford John Radcliffe Women's Hospital

 Lisa Buck, Research Midwife Tel: 01865 221120 

Rotherham General Hospital, S Yorkshire

Rachel Walker, Reseach nurse:  0109 426066 Ext@6066  

Southampton,Princess Anne Hospital

Abby Rand. Research nurse. E-mail 02381 206 856 


For more information about the hospitals recruiting and how to get in touch, please visit the trial website
If you have any questions that are not medical or scientific and more about feelings or concerns about the trial, do contact us at